Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02042924 · ClinicalTrials.gov registry record · NA
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02042924 is a NA study that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 2 participants.
The verdict
NCT02042924, a NA study, was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a pilot sub-study of patients receiving myeloablative transplant using total body irradiation (TBI) or total marrow irradiation (TMI) in their preparative regimen. The objective of this stub-study is to estimate the heterogeneity in cellular proliferation (FLT-PET uptake) as well the heterogeneity in marrow composition distribution (measured using whole body water-fat MRI) using positron emission tomography imaging. This will be used to design future trials as well as to determine the feasibility of PET and MRI imaging.
Interventions
- DEVICE MRI
- RADIATION FLT PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02042924
The ClinicalTrials.gov registry entry for NCT02042924 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02042924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02042924 about?
NCT02042924 is a clinical study titled "Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies". This is a pilot sub-study of patients receiving myeloablative transplant using total body irradiation (TBI) or total marrow irradiation (TMI) in their preparative regimen. The objective of this stub-study is to estimate the heterogeneity in cellular proliferation (FLT-PET uptake) as well the heterog...
What is the current status of trial NCT02042924?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2014-01. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02042924?
The interventions under investigation include: MRI (DEVICE), FLT PET/CT (RADIATION).
Who is sponsoring clinical trial NCT02042924?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.